HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shot up 0.6% during trading on Thursday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The business has a 50 day simple moving average of $25.31 and a two-hundred day simple moving average of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Recommended Stories
- Five stocks we like better than HemaCare
- Election Stocks: How Elections Affect the Stock Market
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- How to Capture the Benefits of Dividend Increases
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Read Stock Charts for Beginners
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
